Complex Hospitalari Universitari Moisès Broggi, Barcelona, Spain.
Eyes of the world Foundation, Barcelona, Spain.
BMC Ophthalmol. 2023 Jul 13;23(1):317. doi: 10.1186/s12886-023-03058-1.
Cataracts are the world's leading cause of avoidable blindness. In low-income countries, there are high rates of poor follow-up, which makes it very difficult to monitor surgical outcomes. To address this issue, the Better Operative Outcome Software Tool (BOOST Cataract app) predicts outcome on the first postoperative day and provides specific advice to improve outcomes. The aim of the study is to evaluate the ability of the BOOST Cataract app to categorise surgical outcomes and to analyse the possible factors that contribute to its performance. This was a prospective observational study performed at the General Hospital of Hospitalet of Llobregat.
A total of 126 cataracts were included. Patients had a mean [SD] age of 75.8 [12.19] years, and 52% were females. Manual small-incision cataract surgery was involved in 57% and phacoemulsification in 43%. Thirty-eight percent of eyes presented significant corneal oedema on day 1. The BOOST Cataract app succeeded in categorising the final outcome in 65.6% of the eyes and in 93,4% of the eyes with good outcome.The agreement between the BOOST and UDVA outcomes was 0.353 (p< .000). The level of agreement improved to 0.619 (p< .000) in eyes with clear corneas. Success obtained by BOOST for both types of surgery was not statistically different. Eyes that obtained a good outcome on day one after surgery and eyes with clear cornea had 37 times higher odds (95% CI 6.66, 212.83) and 12 times higher odds (95% CI 3.13, 47.66) of being correctly categorised by the BOOST Cataract app than eyes that obtained a suboptimal (moderate and poor) outcome and eyes with corneal oedema on day 1.
The BOOST Cataract app is an e-Health tool designed to address issues of measuring quality in low- and middle-income settings. Although its reliability is limited to eyes that obtain a good outcome and with clear corneas on day 1, the use of the tool on a regular basis facilitates monitoring and reporting outcomes when clinical data collection is challenging due to low postoperative follow-up rates.
白内障是全球可避免盲的首要病因。在低收入国家,术后随访率很低,这使得监测手术效果变得非常困难。为了解决这个问题,Better Operative Outcome Software Tool(BOOST 白内障应用程序)可以在术后第一天预测手术效果,并提供具体的建议以改善效果。本研究旨在评估 BOOST 白内障应用程序对手术效果分类的能力,并分析影响其性能的可能因素。这是在西班牙巴塞罗那省的 Hospitalet de Llobregat 总医院进行的一项前瞻性观察研究。
共纳入 126 例白内障患者。患者的平均(标准差)年龄为 75.8(12.19)岁,52%为女性。57%的患者接受了小切口白内障手术,43%的患者接受了超声乳化白内障吸除术。38%的患者在术后第一天出现明显的角膜水肿。BOOST 白内障应用程序成功地对 65.6%的患者的最终效果进行了分类,对 93.4%的预后良好的患者进行了分类。BOOST 与 UDVA 结果的一致性为 0.353(p<0.000)。在角膜透明的患者中,一致性提高到 0.619(p<0.000)。两种手术类型的 BOOST 成功率无统计学差异。术后第一天效果良好的患者和角膜透明的患者,其 BOOST 白内障应用程序分类正确的可能性分别是获得不佳(中度和差)效果和第一天有角膜水肿的患者的 37 倍(95%CI 6.66,212.83)和 12 倍(95%CI 3.13,47.66)。
BOOST 白内障应用程序是一种电子医疗工具,旨在解决中低收入国家衡量质量的问题。虽然其可靠性仅限于术后第一天获得良好效果且角膜透明的患者,但在术后随访率低导致临床数据收集困难时,定期使用该工具可以方便地监测和报告效果。